Circulating tumor DNA monitoring in participants with ovarian cancer treated with neoadjuvant pembrolizumab plus chemotherapy with or withou

Lee J-Y, Ibañez C; Bidzinski M, et al. ASCO Annual Meeting 2025, Chicago, IL. May 30 - June 3, 2025.